Wednesday, 05 Nov 2025

Exploring Adenosine A3 as a Novel Target for Trigeminal Neuropathic Pain: Marcela Romero-Reyes, DDS, PhD, FAHS

Written by
Neurology Live
Published
The director of the Brotman Facial Pain Clinic at the University of Maryland talked about emerging preclinical evidence supporting adenosine A3 receptor activation for post-traumatic trigeminal neuropathic pain. [WATCH TIME: 5 minutes]
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago